Código QR (código de barras bidimensional)

INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia

The Tunisian Health Technology Assessment (HTA) body, INEAS, conducted a cost-effectiveness analysis (CEA) of vemurafenib in the treatment of locally advanced or metastatic BRAF V600-mutated melanoma. The objective of this analysis was to enable the use of value-based pricing as a new approach to pr...

Fuld beskrivelse

Na minha lista:
Principais autores: Mouna Jameleddine, Nabil Harzallah, Hela Grati, Marie Christine Odabachian Jebali, Jaafar Chemli, Sebastián García Martí, Natalie Soto, Andrés Pichon-Riviere, Chokri Hamouda
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2024-10-01
Serier:Journal of Market Access & Health Policy
Fag:
vemurafenib
advanced melanoma
targeted therapy
BRAF V600
cost-effectiveness
cost utility
Online adgang:https://www.mdpi.com/2001-6689/12/4/23
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker